Rydex Health Care Fund Class C (RYHCX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
88.30
-0.92 (-1.03%)
Mar 11, 2025, 5:00 PM EST
-3.34% (1Y)
| Fund Assets | 26.49M |
| Expense Ratio | 2.40% |
| Min. Investment | $2,500 |
| Turnover | n/a |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Dividend Growth | n/a |
| Payout Frequency | n/a |
| Ex-Dividend Date | n/a |
| Previous Close | 89.22 |
| YTD Return | 2.88% |
| 1-Year Return | -3.34% |
| 5-Year Return | 47.91% |
| 52-Week Low | n/a |
| 52-Week High | n/a |
| Beta (5Y) | 0.76 |
| Holdings | 127 |
| Inception Date | Mar 30, 2001 |
About RYHCX
The Fund's investment strategy focuses on Health/Biotech with 2.48% total expense ratio. The minimum amount to invest in Rydex Series Funds: Health Care Fund; C-Class Shares is $2,500 on a standard taxable account. Rydex Series Funds: Health Care Fund; C-Class Shares seeks capital appreciation by investing in companies that are involved in the health care industry.
Category Health
Performance Rating Average
Risk Rating Average
Stock Exchange NASDAQ
Ticker Symbol RYHCX
Share Class Class C
Index S&P 500 TR
Performance
RYHCX had a total return of -3.34% in the past year. Since the fund's inception, the average annual return has been 7.04%, including dividends.
Equivalent Funds
These are funds that follow the same index from the other major fund companies.
| Symbol | Provider | Name | Expense Ratio |
|---|---|---|---|
| undefined | Fidelity | Fidelity Advisor Health Care Fund - Class Z | 0.59% |
| undefined | Fidelity | Fidelity Select Health Care Portfolio | 0.65% |
| undefined | Fidelity | Fidelity Advisor Biotechnology Fund - Class Z | 0.61% |
| undefined | Fidelity | Fidelity Advisor Health Care Fund - Class A | 0.98% |
| undefined | Fidelity | Fidelity Select Health Care Services Portfolio | 0.68% |
Top 10 Holdings
26.00% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 4.00% |
| UnitedHealth Group Incorporated | UNH | 3.35% |
| Johnson & Johnson | JNJ | 2.94% |
| AbbVie Inc. | ABBV | 2.83% |
| Merck & Co., Inc. | MRK | 2.48% |
| Thermo Fisher Scientific Inc. | TMO | 2.22% |
| Abbott Laboratories | ABT | 2.20% |
| Intuitive Surgical, Inc. | ISRG | 2.09% |
| Pfizer Inc. | PFE | 1.98% |
| Danaher Corporation | DHR | 1.92% |